Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
First use of alemtuzumab in Balo's concentric sclerosis: a case report.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Multiple sclerosis and breast cancer.
Glatiramer acetate (copaxone) modulates platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation.
Keystone Symposium on Growing to Extremes: Cell Biology and Pathology of Axons
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
ISMRM Workshop on Multiple Sclerosis as a Whole-Brain Disease
Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
Time limited immunomodulatory functions of transplanted neural precursor cells.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
Anejaculatory infertility due to multiple sclerosis.
Epstein-Barr virus: an important vaccine target for cancer prevention.
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
141
142
143
144
145
146
147
148
149
…
next ›
last »